A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell's viper antivenom in Myanmar
For most antivenoms there is little information from clinical studies to infer the relationship between dose and efficacy or dose and toxicity. Antivenom dose-finding studies usually recruit too few patients (e.g. fewer than 20) relative to clinically significant event rates (e.g. 5%). Model based a...
Prif Awduron: | Watson, JA, Lamb, T, Holmes, J, Warrell, DA, Thwin, KT, Aung, ZL, Oo, MZ, Nwe, MT, Smithuis, F, Ashley, EA |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Public Library of Science
2020
|
Eitemau Tebyg
-
A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell's viper antivenom in Myanmar.
gan: James A Watson, et al.
Cyhoeddwyd: (2020-11-01) -
HEMOSTATIC DEFECTS AND THEIR RESPONSE TO SPECIFIC ANTIVENOM THERAPY IN SEVERELY ENVENOMATED RUSSELL VIPER BITE VICTIMS
gan: Than, T, et al.
Cyhoeddwyd: (1988) -
Translational Venomics: Third-Generation Antivenomics of Anti-Siamese Russell’s Viper, Daboia siamensis, Antivenom Manufactured in Taiwan CDC’s Vaccine Center
gan: Libia Sanz, et al.
Cyhoeddwyd: (2018-06-01) -
In Vitro Toxicity of Chinese Russell’s Viper (<i>Daboia siamensis</i>) Venom and Neutralisation by Antivenoms
gan: Mimi Lay, et al.
Cyhoeddwyd: (2022-07-01) -
Proteomics, toxicity and antivenom neutralization of Sri Lankan and Indian Russell’s viper (Daboia russelii) venoms
gan: Tasnim Faisal, et al.
Cyhoeddwyd: (2021-04-01)